BiotechTube
Luciole Medical

Luciole Medical

Lausanne, Switzerland· Est.
luciolemedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Luciole Medical is a pioneering medical device company focused on advanced cerebral monitoring. It has established a first-mover position with the only CE-marked and MDR-certified system combining a non-invasive patch, an intracranial probe, and a proprietary analytics platform to measure cerebral oxygenation and blood flow. The company aims to revolutionize individualized brain health monitoring across hospital settings, from surgery and anesthesia to neurocritical care, and is developing a wearable device for broader brain health tracking. Its 2023 acquisition of Spiegelberg GmbH expanded its portfolio into specialized intracranial pressure monitoring.

NeurologyCritical CareSurgical Care

Technology Platform

Proprietary Near-Infrared Spectroscopy (NIRS) system with multi-wavelength lasers, dual-depth sensing, and algorithms for measuring cerebral oxygenation and blood flow. Integrated platform includes non-invasive patch, intracranial probe, and analytics software.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The large and growing neuromonitoring market, driven by an aging population and focus on surgical outcomes, presents a major opportunity.
Luciole's unique capability to non-invasively measure cerebral blood flow—a key unmet need—differentiates it and allows penetration into high-value clinical segments like cardiac surgery and neuro-ICU.
Expansion into wearable brain health opens a new, massive market for preventive and longitudinal monitoring.

Risk Factors

Commercialization risk is high in a competitive market with established players.
Regulatory hurdles, particularly for the wearable device and potential FDA clearance, are significant.
The company must consistently prove the clinical utility and cost-effectiveness of its advanced monitoring to drive hospital adoption over simpler, cheaper alternatives.

Competitive Landscape

Luciole competes with established medtech companies offering cerebral oximetry (e.g., Medtronic, Edwards Lifesciences, Masimo) and invasive neuromonitoring devices. Its key differentiation is the patented non-invasive cerebral blood flow measurement and the validated correlation between its patch and invasive probe data. The acquisition of Spiegelberg also places it in direct competition with other ICP monitoring specialists like Integra LifeSciences.

More companies in Switzerland →